Kung-Yen Chang

Kung-Yen Chang is a Senior Computational Biologist at Foundation Medicine since May 2021, where expertise in developing computational pipelines for tumor and healthy samples is demonstrated through software such as Python and AWS. Prior experience includes roles at Illumina from November 2014 to April 2021, where significant contributions were made as a Bioinformatics Scientist and in software testing, including the release of the TruSight Tumor 170 assay. Additionally, Chang served as a Postdoctoral Fellow at Sanford Burnham Prebys Medical Discovery Institute from January 2012 to November 2014, focusing on non-coding RNAs in cancer. An academic background includes a Ph.D. in Bioinformatics from North Carolina State University and multiple master's degrees from New York University and National Yang Ming University, culminating in a B.S. in Chemistry from National Tsing Hua University.